PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Wuling Motors Holdings Limited (0305.HK)
0.700.02 (-2.78%)
0.68 - 0.75
0.33 - 0.86
12.91M / 4.66M (Avg.)
35.00 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
69.45%
Revenue growth above 1.5x 0259.HK's 4.77%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
283.79%
Positive gross profit growth while 0259.HK is negative. John Neff would see a clear operational edge over the competitor.
229.63%
Positive EBIT growth while 0259.HK is negative. John Neff might see a substantial edge in operational management.
229.63%
Positive operating income growth while 0259.HK is negative. John Neff might view this as a competitive edge in operations.
183.19%
Net income growth above 1.5x 0259.HK's 30.98%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
171.60%
EPS growth above 1.5x 0259.HK's 33.17%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
171.60%
Diluted EPS growth above 1.5x 0259.HK's 33.98%. David Dodd would see if there's a robust moat protecting these shareholder gains.
16.23%
Share count expansion well above 0259.HK's 0.45%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
16.16%
Slight or no buyback while 0259.HK is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
-5.02%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-3.95%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-25.20%
Negative 10Y revenue/share CAGR while 0259.HK stands at 44.32%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-14.92%
Negative 5Y CAGR while 0259.HK stands at 16.37%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
78.46%
3Y revenue/share CAGR above 1.5x 0259.HK's 5.14%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-879.87%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-38.06%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-2020.15%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
618.94%
Positive 10Y CAGR while 0259.HK is negative. John Neff might see a substantial advantage in bottom-line trajectory.
82.63%
Positive 5Y CAGR while 0259.HK is negative. John Neff might view this as a strong mid-term relative advantage.
135.49%
3Y net income/share CAGR similar to 0259.HK's 142.65%. Walter Schloss would attribute it to shared growth factors or demand patterns.
109.13%
10Y equity/share CAGR above 1.5x 0259.HK's 33.93%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
-16.14%
Negative 5Y equity/share growth while 0259.HK is at 62.81%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
41.33%
3Y equity/share CAGR above 1.5x 0259.HK's 18.51%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
-91.69%
Cut dividends over 10 years while 0259.HK stands at 893.80%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
8.95%
AR growth is negative/stable vs. 0259.HK's 62.98%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
-33.37%
Inventory is declining while 0259.HK stands at 47.14%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-10.25%
Negative asset growth while 0259.HK invests at 8.09%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-1.50%
We have a declining book value while 0259.HK shows 10.06%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-55.61%
We’re deleveraging while 0259.HK stands at 22.96%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-0.41%
Our R&D shrinks while 0259.HK invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
71.83%
SG&A growth well above 0259.HK's 2.76%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.